Ensign Peak Advisors
ASTH icon

Ensign Peak Advisors’s Astrana Health ASTH Stock Holding History

Ensign Peak Advisors’s Portfolio ASTH Stock Details ASTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-9,650
Closed -$376K – 2249
2022
Q3 		$376K Hold
9,650
– – ﹤0.01% 1605
2022
Q2 		$372K Hold
9,650
– – ﹤0.01% 1582
2022
Q1 		$468K Hold
9,650
– – ﹤0.01% 1577
2021
Q4 		$709K Sell
9,650
-14,250
-60% -$1.17M ﹤0.01% 1456
2021
Q3 		$2.18M Buy
+23,900
New +$2.03M ﹤0.01% 1074

Other funds holding ASTH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
AWS
Atria Wealth Solutions New York $4.42B AUM 16.4% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
3C
325 Capital New York $274M AUM 49.96% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return

Ensign Peak Advisors's ASTH Position: Q4 2022 in Review

Ensign Peak Advisors sold out of Astrana Health (ASTH) in Q4 2022, closing a stake of 9,650 shares — an estimated $376K sold.

Ensign Peak Advisors first reported a position in ASTH in Q3 2021 and held it in 5 quarters. The position peaked at $2.18M in Q3 2021. 130 funds tracked by Wall St. Rank hold ASTH as of Q4 2022.

  • Ensign Peak Advisors reported no remaining Astrana Health position as of Q4 2022 after selling out during the quarter.
  • Ensign Peak Advisors sold 9,650 Astrana Health shares in Q4 2022, an estimated $376K.
  • Ensign Peak Advisors first reported a position in Astrana Health in Q3 2021 and held it in 5 quarters.
  • Ensign Peak Advisors's Astrana Health position peaked at $2.18M in Q3 2021.
  • 130 funds tracked by Wall St. Rank held Astrana Health as of Q4 2022.

Based on Ensign Peak Advisors's 13F filing for Q4 2022, filed 13 Feb 2023.